PMID- 34856011
OWN - NLM
STAT- MEDLINE
DCOM- 20220401
LR  - 20220531
IS  - 1365-2230 (Electronic)
IS  - 0307-6938 (Linking)
VI  - 47
IP  - 4
DP  - 2022 Apr
TI  - Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with 
      concomitant frontal fibrosing alopecia.
PG  - 787-788
LID - 10.1111/ced.15044 [doi]
AB  - We read with great interest the recently published article by Joos et al. on the 
      successful use of baricitinib for cutaneous lupus erythematosus. The authors 
      presented a heavily pretreated case of subacute cutaneous lupus erythematosus 
      (SCLE) with almost complete clearance following 6 months of baricitinib therapy. 
      We would like to add our experiences of baricitinib for SCLE in a patient with 
      concomitant frontal fibrosing alopecia.
CI  - (c) 2021 British Association of Dermatologists.
FAU - Kreuter, Alexander
AU  - Kreuter A
AUID- ORCID: 0000-0003-2275-499X
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, 
      Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
FAU - Licciardi-Fernandez, Maximiliano J
AU  - Licciardi-Fernandez MJ
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, 
      Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
FAU - Burmann, Sven-Niklas
AU  - Burmann SN
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, 
      Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
FAU - Paschos, Alexandros
AU  - Paschos A
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, 
      Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
FAU - Michalowitz, Alena-Lioba
AU  - Michalowitz AL
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, 
      Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
LA  - eng
PT  - Case Reports
PT  - Letter
DEP - 20220118
PL  - England
TA  - Clin Exp Dermatol
JT  - Clinical and experimental dermatology
JID - 7606847
RN  - 0 (Azetidines)
RN  - 0 (Purines)
RN  - 0 (Pyrazoles)
RN  - 0 (Sulfonamides)
RN  - ISP4442I3Y (baricitinib)
SB  - IM
MH  - Alopecia/complications/drug therapy
MH  - Azetidines
MH  - Humans
MH  - *Lichen Planus/complications/drug therapy
MH  - *Lupus Erythematosus, Cutaneous/complications/drug therapy
MH  - Purines
MH  - Pyrazoles
MH  - Sulfonamides
EDAT- 2021/12/03 06:00
MHDA- 2022/04/02 06:00
CRDT- 2021/12/02 17:40
PHST- 2021/11/23 00:00 [received]
PHST- 2021/11/29 00:00 [accepted]
PHST- 2021/12/03 06:00 [pubmed]
PHST- 2022/04/02 06:00 [medline]
PHST- 2021/12/02 17:40 [entrez]
AID - 10.1111/ced.15044 [doi]
PST - ppublish
SO  - Clin Exp Dermatol. 2022 Apr;47(4):787-788. doi: 10.1111/ced.15044. Epub 2022 Jan 
      18.